Free Trial
→ I’m sounding the alarm (From Porter & Company) (Ad)tc pixel Free SLRX Stock Alerts

This company has been marked as potentially delisted and may not be actively trading.

Salarius Pharmaceuticals (SLRX) Short Interest Ratio & Short Volume

Salarius Pharmaceuticals logo
Compare

Salarius Pharmaceuticals Short Interest Overview

As of December 31, 2025, Salarius Pharmaceuticals (SLRX) had a short interest of 223,283 shares sold short, representing 3.82% of the public float. This marks a 20.93% increase in short interest since the prior report. The short interest ratio (days to cover) is 1.0, meaning it would take 1.0 days of the average trading volume of 808,890 shares to cover all short positions.

Current Short Interest
223,283 shares
Previous Short Interest
184,642 shares
Change Vs. Previous Month
20.93%
Dollar Volume Sold Short
$144.87 thousand
Short Interest Ratio
1.0 Days to Cover
Last Record Date
December 31, 2025
Outstanding Shares
5,862,000 shares
Short Percent of Float
3.82%
Today's Trading Volume
5,993,436 shares
Average Trading Volume
808,890 shares
Today's Volume Vs. Average
741%
Short Selling Salarius Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Salarius Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

SLRX Short Interest Over Time

SLRX Days to Cover Over Time

SLRX Percentage of Float Shorted Over Time

Salarius Pharmaceuticals Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
12/31/2025223,283 shares $144.87 thousand +20.9%3.8%0.97 $0.65
12/15/2025184,642 shares $144.02 thousand +0.2%3.2%0.51 $0.78
11/28/2025184,255 shares $170.99 thousand -60.6%3.2%0.21 $0.93
11/14/2025467,881 shares $561.46 thousand +29.9%8.0%0.05 $1.20
10/31/2025360,165 shares $1.40 million +2.3%71.5%3.57 $3.89
10/15/2025352,100 shares $1.62 million +200.9%33.5%1 $4.60
9/30/2025117,000 shares $429.39 thousand +115.9%12.5%0.4 $3.67
9/15/202554,200 shares $295.39 thousand -56.2%10.7%0.2 $5.45
8/31/2025123,800 shares $713.09 thousand +56.5%24.5%0.5 $5.76
8/15/202579,100 shares $547.93 thousand -90.2%15.6%0.4 $6.93
7/31/2025803,600 shares $481.60 thousand +18.4%10.6%0.3 $0.60
7/15/2025678,500 shares $460.70 thousand -3.9%32.2%0.6 $0.68
6/30/2025705,800 shares $632.33 thousand +2,147.8%33.5%0.6 $0.90
6/15/202531,400 shares $20.64 thousand -34.6%1.5%0 $0.66
5/31/202548,000 shares $37.44 thousand -8.9%2.3%0.2 $0.78
5/15/202552,700 shares $44.78 thousand -37.4%2.5%0.2 $0.85
4/30/202584,200 shares $59.78 thousand -25.4%4.1%0.3 $0.71
4/15/2025112,900 shares $81.29 thousand -18.3%5.4%0.4 $0.72
3/31/2025138,200 shares $104.20 thousand +242.1%8.1%0.1 $0.75
3/15/202540,400 shares $39.19 thousand -52.9%2.4%0 $0.97
2/28/202585,700 shares $92.56 thousand +724.0%5.5%0 $1.08
2/15/202510,400 shares $16.85 thousand -46.1%0.7%0 $1.62
1/31/202519,300 shares $43.23 thousand -93.8%1.3%0 $2.24
1/15/2025311,700 shares $785.48 thousand +902.3%20.2%0.2 $2.52
12/31/202431,100 shares $57.22 thousand +18.3%2.2%0.1 $1.84
12/15/202426,300 shares $38.66 thousand -27.8%1.9%0.1 $1.47
11/30/202436,400 shares $52.05 thousand -33.8%2.6%0.1 $1.43
11/15/202455,000 shares $73.70 thousand -15.4%3.9%0.2 $1.34
10/31/202465,000 shares $104.65 thousand +4,233.3%4.6%0.2 $1.61
10/15/20241,500 shares $2.28 thousand -90.0%0.1%0 $1.52
9/30/202415,000 shares $21.60 thousand +59.6%1.1%0 $1.44
9/15/20249,400 shares $14.66 thousand -38.6%0.7%0 $1.56
8/31/202415,300 shares $25.40 thousand -64.0%1.1%0 $1.66
8/15/202442,500 shares $85.43 thousand -50.8%3.2%0 $2.01
7/31/202486,300 shares $220.93 thousand +44.1%15.4%0 $2.56
7/15/202459,900 shares $106.62 thousand +215.3%10.7%0 $1.78
6/30/202419,000 shares $45.22 thousand +375.0%27.1%0.9 $2.38
6/15/20244,000 shares $13.53 thousand -85.4%5.7%0.2 $3.38
5/31/202427,300 shares $12.65 thousand -18.5%0.6%0.2 $0.46
5/15/202433,500 shares $15.34 thousand -54.5%0.8%0.3 $0.46
4/30/202473,600 shares $36.73 thousand -36.3%1.7%0.6 $0.50
4/15/2024115,600 shares $57.80 thousand -57.0%2.6%1 $0.50
3/31/2024268,900 shares $142.14 thousand +1,767.4%6.7%2.4 $0.53
3/15/202414,400 shares $9.36 thousand -20.0%0.4%0.1 $0.65
2/29/202418,000 shares $12.06 thousand +227.3%0.5%0.6 $0.67
2/15/20245,500 shares $3.25 thousand -33.7%0.2%0.2 $0.59
1/31/20248,300 shares $4.56 thousand +36.1%0.2%0.2 $0.55
1/15/20246,100 shares $3.72 thousand -37.1%0.2%0.2 $0.61
12/31/20239,700 shares $6.31 thousand +38.6%0.3%0.3 $0.65
12/15/20237,000 shares $4.52 thousand -71.9%0.2%0.1 $0.65
11/30/202324,900 shares $17.68 thousand -56.0%0.7%0.4 $0.71
11/15/202356,600 shares $40.75 thousand -22.7%1.6%1.1 $0.72
10/31/202373,200 shares $61.33 thousand +136.9%2.3%1.2 $0.84
10/15/202330,900 shares $21.32 thousand +62.6%0.9%0.5 $0.69
9/30/202319,000 shares $12.50 thousand -6.4%0.6%0.3 $0.66
9/15/202320,300 shares $17.40 thousand -26.5%0.6%0.4 $0.86
8/31/202327,600 shares $24.29 thousand +162.9%0.8%0.5 $0.88
8/15/202310,500 shares $7.49 thousand +54.4%0.3%0.2 $0.71
7/31/20236,800 shares $6.25 thousand -60.9%0.2%0.1 $0.92
7/15/202317,400 shares $19.31 thousand -44.8%0.6%0.2 $1.11
6/30/202331,500 shares $46.94 thousand -41.2%1.0%0.3 $1.49
6/15/202353,600 shares $85.22 thousand +9.6%1.7%0.5 $1.59
5/31/202348,900 shares $68.95 thousand -48.4%2.1%0.5 $1.41
5/15/202394,700 shares $136.37 thousand -16.1%4.2%1 $1.44
4/30/2023112,800 shares $200.78 thousand -11.9%5.4%1.3 $1.78
4/15/2023128,000 shares $220.16 thousand +6.1%6.1%2.5 $1.72
3/31/2023120,700 shares $230.54 thousand -4.2%5.8%0.8 $1.91
3/15/2023126,000 shares $255.78 thousand -4.0%6.6%0.7 $2.03
2/28/2023131,300 shares $279.67 thousand +16.7%6.8%0.7 $2.13
2/15/2023112,500 shares $252.00 thousand +11.3%5.9%0.6 $2.24
1/31/2023101,100 shares $260.84 thousand +37.7%5.2%0.6 $2.58
1/15/202373,400 shares $194.51 thousand +272.6%3.8%0.4 $2.65
12/30/202219,700 shares $30.14 thousand -46.6%1.0%0.3 $1.53
12/15/202236,900 shares $55.72 thousand +93.2%1.9%0.8 $1.51
11/30/202219,100 shares $36.86 thousand -12.0%1.0%0.4 $1.93
11/15/202221,700 shares $46.66 thousand +100.9%1.1%0.5 $2.15
10/31/202210,800 shares $21.92 thousand -31.2%0.5%0.3 $2.03
10/15/202215,700 shares $71.04 thousand -95.8%0.8%0.4 $4.53
9/30/2022371,000 shares $72.35 thousand -8.4%N/A0.9 $0.20
9/15/2022405,000 shares $95.90 thousand +9.6%N/A0.8 $0.24
8/31/2022369,500 shares $74.27 thousand -16.3%N/A0.7 $0.20
8/15/2022441,600 shares $99.36 thousand +257.3%N/A0.7 $0.23
7/31/2022123,600 shares $23.51 thousand +7.3%N/A0.1 $0.19
7/15/2022115,200 shares $21.88 thousand -33.8%N/A0.1 $0.19
6/30/2022174,100 shares $36.56 thousand -54.6%N/A0.1 $0.21
6/15/2022383,300 shares $77.73 thousand -9.8%N/A0.3 $0.20
5/31/2022425,000 shares $76.63 thousand -3.8%N/A0.4 $0.18
5/15/2022441,800 shares $83.01 thousand -26.6%N/A0.4 $0.19
4/30/2022602,200 shares $121.64 thousand +31.4%N/A1.1 $0.20
4/15/2022458,300 shares $163.66 thousand -14.7%N/A1.1 $0.36
3/31/2022537,100 shares $213.82 thousand +11.7%N/A1.3 $0.40
3/15/2022480,900 shares $165.43 thousand -23.8%N/A1 $0.34
2/28/2022630,900 shares $252.42 thousand +0.4%N/A1.8 $0.40
2/15/2022628,200 shares $285.83 thousand -3.7%N/A1.7 $0.46
1/31/2022652,400 shares $293.58 thousand -2.0%4.5%1.5 $0.45
1/15/2022665,600 shares $312.83 thousand +4.2%4.6%1.4 $0.47
12/31/2021638,500 shares $316.44 thousand -7.3%4.4%1.3 $0.50
12/15/2021688,600 shares $365.85 thousand -35.0%4.7%1.4 $0.53
11/30/20211,060,000 shares $689 thousand +1.0%7.3%1.5 $0.65
11/15/20211,050,000 shares $796.95 thousand +7.5%7.2%1.1 $0.76
10/29/2021976,600 shares $808.33 thousand -0.2%6.7%0.8 $0.83
10/15/2021978,900 shares $886.00 thousand -24.1%6.7%0.8 $0.91
9/30/20211,290,000 shares $1.32 million -4.4%8.9%1 $1.02
9/15/20211,350,000 shares $1.39 million -2.9%9.3%1 $1.03
8/31/20211,390,000 shares $1.45 million +9.5%9.6%1 $1.04
8/13/20211,270,000 shares $1.17 million -8.0%8.8%0.7 $0.92
7/30/20211,380,000 shares $1.12 million -9.2%9.5%0.8 $0.81
7/15/20211,520,000 shares $1.38 million -19.2%10.5%0.9 $0.91
6/30/20211,880,000 shares $1.99 million +0.5%13.0%1.1 $1.06
6/15/20211,870,000 shares $2.24 million +14.7%12.9%1.1 $1.20
5/28/20211,630,000 shares $2.09 million -2.4%11.3%1 $1.28
5/14/20211,670,000 shares $2.04 million +29.5%N/A1.3 $1.22

SLRX Short Interest - Frequently Asked Questions

What is Salarius Pharmaceuticals' current short interest?

Short interest is the volume of Salarius Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of December 31st, traders have sold 223,283 shares of SLRX short. 3.82% of Salarius Pharmaceuticals' shares are currently sold short. Learn More on Salarius Pharmaceuticals' current short interest.

What is a good short interest ratio for Salarius Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SLRX shares currently have a short interest ratio of 1.0. Learn More on Salarius Pharmaceuticals's short interest ratio.

What is a good short interest percentage for Salarius Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.82% of Salarius Pharmaceuticals' floating shares are currently sold short.

Is Salarius Pharmaceuticals' short interest increasing or decreasing?

Salarius Pharmaceuticals saw a increase in short interest in December. As of December 31st, there was short interest totaling 223,283 shares, an increase of 20.9% from the previous total of 184,642 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Salarius Pharmaceuticals' short interest compare to its competitors?

3.82% of Salarius Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Salarius Pharmaceuticals: Cocrystal Pharma, Inc. (9.98%), Lexaria Bioscience Corp. (1.69%), Anebulo Pharmaceuticals, Inc. (1.77%), Quantum Biopharma Ltd. (5.18%), Lipocine Inc. (2.25%), Passage Bio, Inc. (2.23%), Cadrenal Therapeutics, Inc. (2.35%), Pasithea Therapeutics Corp. (0.93%), Natural Alternatives International, Inc. (0.11%), Genenta Science S.p.A. Unsponsored ADR (0.37%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($68.76 billion), Invesco QQQ ($26.44 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($12.46 billion), AppLovin Corporation ($10.57 billion), SPDR S&P Biotech ETF ($9.48 billion), Palo Alto Networks, Inc. ($8.67 billion), Carvana Co. ($6.81 billion), Western Digital Corporation ($6.35 billion), and iShares MSCI Emerging Markets ETF ($6.03 billion). View all of the most shorted stocks.

What does it mean to sell short Salarius Pharmaceuticals stock?

Short selling SLRX is an investing strategy that aims to generate trading profit from Salarius Pharmaceuticals as its price is falling. SLRX shares are trading up $0.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Salarius Pharmaceuticals?

A short squeeze for Salarius Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SLRX, which in turn drives the price of the stock up even further.

How often is Salarius Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLRX, twice per month. The most recent reporting period available is December, 31 2025.

What do SLRX's short interest metrics mean?

Understanding short interest metrics can help you assess how traders are positioning around a stock like SLRX:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Related Companies
Short Interest Tools

This page (NASDAQ:SLRX) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...
Weiss Ratings | Sponsoredtc pixel
How to collect $1,170/month from silver
There is a silver fund paying up to 20% in yearly distributions - no mining stocks, no options required. The s...
Investors Alley | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
A U.S. Resource Gap Is a National Issue - and Opportunity
America still does not domestically produce one mineral tied to batteries, energy storage, and national defens...
i2i Marketing Group, LLC | Sponsoredtc pixel